debt
confidence high
sentiment neutral
materiality 0.60
Senti Biosciences files $300M shelf registration and enters ATM sales agreement with Leerink Partners
Senti Biosciences, Inc.
- Filed Form S-3 to register up to $300M of common stock, preferred, debt, warrants, and units.
- Entered into ATM agreement with Leerink Partners for at-the-market sales of common stock.
- Pays Leerink 3.0% commission on gross proceeds; no minimum sales obligation.
- Sales may occur on Nasdaq or other trading markets; Company can suspend or terminate.